{
  "id": 2223857,
  "title": "BioSyent Releases Financial Results for Q2 and H1 2026",
  "url": "https://urgent.news/2026/08/20/biosyent-releases-financial-results-for-q2-and-h1-2026",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-20T21:01:02.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/biosyent-releases-financial-results-for-q2-and-h1-2026"
  },
  "original_language": "en",
  "account": null,
  "summary": "MISSISSAUGA, Ontario, Aug. 20, 2026 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its consolidated financial results for the three months (Q2), six months (H1), and trailing twelve months (TTM) ended June 30, 2026. Key highlights include: (CAD) Q2 2026 % Changevs. Q2 2025 H1 2026 % Changevs. […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}